Completed NA INTERVENTIONAL 2-arm NCT02356770

A Clinical Study to Investigate Collagen Matrix 10808 for Soft Tissue Volume Augmentation Around Single Implants

Randomized Controlled Clinical Study to Investigate Effectiveness and Safety of a Collagen Matrix 10808 for Soft Tissue Volume Augmentation After Implant Placement in Single Tooth Gaps

Sponsor: Geistlich Pharma AG

Conditions Soft Tissue Deficiency Tooth Loss

Interventions Collagen Matrix 10808 Connective tissue graft

Updated 6 times since 2017 Last updated: Feb 22, 2019 Started: Feb 29, 2012 Primary completion: Jul 31, 2013 Completion: Jul 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Soft Tissue Deficiency and Tooth Loss and is currently completed. Geistlich Pharma AG leads this study, which shows 6 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Mar 2019 — Jan 2021 [monthly]

Completed NA
Jun 2018 — Mar 2019 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Feb 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Geistlich Pharma AG

Data source: Geistlich Pharma AG

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zurich, Switzerland